Tumor necrosis factor‐α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia

Tumor necrosis factor‐alpha is a principal mediator of the pathophysiological effects of endotoxemia and endotoxin shock. Tumor necrosis factor‐α also contributes to the stimulation of nitric oxide synthesis by the induction of the enzyme nitric oxide synthase in a variety of tissues. Although the importance of tumor necrosis factor‐α in the induction of nitric oxide synthase activity in vitro is well known, its role in in vivo nitric oxide synthesis has not been convincingly established. We were interested in determining whether tumor necrosis factor‐α plays a significant role in the in vivo induction of nitric oxide synthesis. In Corynebacterium parvum—primed mice, lipopolysaccharide injection resulted in elevated serum tumor necrosis factor‐α levels early and increased hepatic enzyme release (641 ± 80 IU AST/L 22.7 ± 1.9 IU ornithine carbamoyltransferase per liter) and plasma nitrite and nitrate (804 ± 84 μmol/L) 5 hr after lipopolysaccharide injection. Polyclonal rabbit anti‐mouse anti—tumor necrosis factor‐α reduced in vivo tumor necrosis factor‐α levels (1 hr, 7,332 ± 1,492 U tumor necrosis factor‐α per milliliter) and reduced nitric oxide synthesis as measured by plasma nitrite and nitrate (352 ± 69 μmol/L). Polyclonal rabbit anti‐mouse anti—tumor necrosis factor‐α also reduced lipo‐polysaccharide‐induced hepatic enzyme release (428 ± 33 IU AST/L 16.0 ± 2.5 IU ornithine carbamoyltransferase per liter). NG‐monomethyl‐L‐arginine, a competitive inhibitor of nitric oxide synthesis, also decreased plasma nitrite and nitrate (104 ± 9 μmol/L) but increased the lipopolysaccharide‐induced hepatic injury (797 ± 66 IU AST/L 33.1 ± 2.1 IU ornithine carbamoyltransferase per liter). These results show that tumor necrosis factor‐α not only acts as an in vivo signal for the induction of nitric oxide synthesis but also acts as a mediator of the lipopolysaccharide‐induced hepatic injury. The mechanism by which tumor necrosis factor‐α exerts its damaging effect on hepatic cells has not been determined but appears to be independent of its induction of nitric oxide synthesis. (Hepatology 1994;20:1055–1060).

[1]  O. Griffith,et al.  Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.

[2]  T. Billiar,et al.  Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. , 1994, The American journal of physiology.

[3]  L. Stellin,et al.  Multiple system organ failure. , 1993, Annals of surgery.

[4]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[5]  T. Billiar,et al.  Hepatocyte Injury by Activated Neutrophils In Vitro Is Mediated by Proteases , 1993, Annals of surgery.

[6]  T. Billiar,et al.  Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin‐6 by rat Kupffer cells , 1993, Journal of leukocyte biology.

[7]  T. Billiar,et al.  Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical‐mediated hepatic injury , 1992, Journal of leukocyte biology.

[8]  C. Natanson,et al.  N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin , 1992, The Journal of experimental medicine.

[9]  H. Langstein,et al.  Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[10]  S. Moncada,et al.  Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? , 1991, The Lancet.

[11]  P. Vallance,et al.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.

[12]  R. L. Simmons,et al.  Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.

[13]  R. Busse,et al.  Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells , 1990, FEBS letters.

[14]  J. Adams,et al.  Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. , 1990, Biochemical and biophysical research communications.

[15]  T. Billiar,et al.  Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. , 1990, Annals of surgery.

[16]  T. Billiar,et al.  Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. , 1990, Biochemical and biophysical research communications.

[17]  P. Belloni,et al.  Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. , 1990, Journal of the National Cancer Institute.

[18]  M. Meltzer,et al.  Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. , 1990, Journal of immunology.

[19]  H. Ford,et al.  Characterization of wound cytokines in the sponge matrix model. , 1989, Archives of surgery.

[20]  T. Billiar,et al.  Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. , 1989, Blood.

[21]  T. Billiar,et al.  Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells , 1989, The Journal of experimental medicine.

[22]  K. Tracey,et al.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.

[23]  D. Stuehr,et al.  An L-arginine-dependent mechanism mediates kupffer cell inhibition of hepatocyte protein synthesis in vitro , 1989, The Journal of experimental medicine.

[24]  L. Ignarro Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[26]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[27]  D. Fry,et al.  Effective organ blood flow and bioenergy status in murine peritonitis. , 1986, Surgery.

[28]  D. Stern,et al.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.

[29]  B. Beutler,et al.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.

[30]  M. Arthur,et al.  Oxygen-derived free radicals promote hepatic injury in the rat. , 1985, Gastroenterology.

[31]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[32]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[33]  R. L. Fulton,et al.  Multiple system organ failure. The role of uncontrolled infection. , 1980, Archives of surgery.

[34]  M. Chiasson,et al.  Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. , 1977, Journal of the National Cancer Institute.

[35]  Ozawa Kazue,et al.  A direct method for the estimation of ornithine carbamoyltransferase activity in serum. , 1976 .

[36]  C. Dinarello Interleukin-1 and its biologically related cytokines. , 1989, Advances in immunology.

[37]  H. Schlayer,et al.  Enhancement of neutrophil adherence to isolated rat liver sinusoidal endothelial cells by supernatants of lipopolysaccharide-activated monocytes. Role of tumor necrosis factor. , 1987, Journal of hepatology.

[38]  J. Adams,et al.  hypotension: Implications for the involvement of nitric oxide , 2022 .